Article -> Article Details

Market Research Future (MRFR)’s latest report projects that the global pharmaceutical robots market is set to exhibit substantial growth over the next couple of years. The growth is attributable to the strong value maintained by the pharmaceutical industry. The utilization of robots mitigates the production cost and human labor, which is likely to accelerate its adoption in the forthcoming years.

Laboratory automation is one of the most significant drivers of the global pharmaceutical robots market. It aids easy and timely accomplishments of the tasks such as transferring, capping, uncapping, packaging, etc. as well as eliminates human errors. Furthermore, pharmaceuticals robotics are extensively used for scientific researches, drug discoveries, blood testing, etc. This, in turn, is projected to have a favorable impact on the expansion of the market in the coming years.

The growth of the pharmaceutical industry directly reflects on the rapid expansion of the pharmaceutical robots market. The factors that have led to the acceleration of revenue creation for key vendors include reduction of drugs’ price, optimum utilization of floor space, increased flexibility, and enhanced efficiency. The trend is forecasted to perpetuate in the foreseeable future.

Global Market for Pharmaceutical Robots – Segmental Analysis:

MRFR’s report offers a comprehensive analysis of the market based on type, application, and end-user. By type, the market has been segmented into traditional robots and collaborative robots. The traditional robots segment is further sub-segmented into articulated robot, SCARA robots, delta/parallel robots, cartesian robots, dual-arm robots, and others.

By application, the market is segmented into laboratory applications, picking and packaging, and pharmaceutical drugs inspection.

By end-user, the pharmaceutical robots market has been segmented into pharmaceutical companies and research laboratories.

Regional Outlook:

The global pharmaceutical robots market, by region, has been segmented into North America, Europe, Asia Pacific, and the Rest of the World. Asia Pacific is likely to exhibit a steep rise in the growth of the market. Investments are anticipated to flow towards the technology in the upcoming years. The presence of an established pharmaceutical industry coupled with huge market for industrial robots has paved the way for the expansion of the global pharmaceutical robots market in the region.

Europe is expected to accrue a significant amount of revenue in the coming years. The factors responsible for catalyzing the growth of the regional market are the presence of developed industrial robots market and the initiatives undertaken by the European Union for promoting automation of pharmaceutical industry. Germany is projected to contribute significantly towards the proliferation of the regional market.

North America is a vital growth pocket of the global market and is likely to remain highly lucrative over the next couple of years. The consolidation of key players in the region is prognosticated to aid the expansion of the market. Additionally, the pharmaceutical manufacturers are expected to accelerate the adoption of the technology for achieving enhanced operational efficiency.

Global Market for Pharmaceutical Robots – Competitive Dashboard:

Some of the key players operating in the global pharmaceutical robots market include Yaskawa Electric Corporation (Japan), FANUC Corporation (Japan), KUKA AG (Germany), Kawasaki Heavy Industries Ltd. (Japan), Universal Robots A/S (Denmark), ABB Ltd. (Switzerland), Denso Corporation (Japan), Mitsubishi Electric Corporation (Japan), Seiko Epson Corporation (Japan), Marchesini Group S.p.A (Italy), and Shibuya Corporation (Japan).